Linked Data API

Show Search Form

Search Results

1132563
registered interest false more like this
date less than 2019-06-17more like thismore than 2019-06-17
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Medicine: Research more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what assessment of the effect on the UK's future participation in future EU Research Programmes in (a) medical research and (b) drugs of the UK leaving the EU without a deal. more like this
tabling member constituency Mid Sussex more like this
tabling member printed
Sir Nicholas Soames remove filter
uin 265405 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-06-20more like thismore than 2019-06-20
answer text <p>Leaving the European Union with a deal remains the Government’s priority. However, as a responsible Government, we must plan for every eventuality, including ‘no deal’.</p><p>The United Kingdom and the EU have a long record of jointly tackling global challenges, with strong existing links already in place between our research and innovation communities, and we want to continue this important collaboration in science, research and innovation, including in medical research.</p><p>The Government is committed to continuing to back UK researchers and innovators by supporting measures to enable world-class collaborative research, including support for small businesses. The Department for Business, Energy and Industrial Strategy is working with the National Academies, the devolved administrations and UK Research and Innovation to develop ambitious and credible alternatives to association, through which we will enable world class collaborative research.</p><p>In addition, earlier in the year, the Minister of State for Universities, Science, Research and Innovation (Chris Skidmore MP) commissioned Sir Adrian Smith to provide independent advice on international collaboration – specifically on potential future UK funding schemes in the context of the UK’s future ambitions for European and international collaboration on research and innovation. His advice will help set the direction for the implementation of the Government’s ambition to ensure the UK continues to be a global leader in science, research and innovation, and an attractive country for individuals to study and work.</p><p><strong> </strong></p>
answering member constituency Gosport more like this
answering member printed Caroline Dinenage more like this
question first answered
less than 2019-06-20T15:30:04.907Zmore like thismore than 2019-06-20T15:30:04.907Z
answering member
4008
label Biography information for Dame Caroline Dinenage more like this
tabling member
116
label Biography information for Lord Soames of Fletching more like this
1132564
registered interest false more like this
date less than 2019-06-17more like thismore than 2019-06-17
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Clinical Trials: Finance more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what effect the UK leaving the EU without a deal will have on funding of clinical drug trials; if he will make a statement. more like this
tabling member constituency Mid Sussex more like this
tabling member printed
Sir Nicholas Soames remove filter
uin 265406 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-06-20more like thismore than 2019-06-20
answer text <p>The United Kingdom and the European Union have a long record of jointly tackling global challenges, with strong existing links already in place between our research and innovation communities, and we want to continue this important collaboration in science, research and innovation.</p><p>The UK and the EU have agreed a flexible extension of the Article 50 period to 31 October 2019. During this extension period the UK will remain a member of the EU, with all the relevant rights and obligations. This means that the UK will continue to participate in Horizon 2020, the EU’s flagship research and innovation programme, on a Member State basis. Further, this extension period provides time for the Government to seek a deal which will ensure the smooth and orderly withdrawal from the EU. If ratified, the proposed Withdrawal Agreement would ensure that following exit the UK could continue to participate in EU programmes such as Horizon 2020 for the lifetime of projects. Further updates on Horizon 2020 planning will be provided in due course.</p><p>As a responsible Government, we are continuing to prepare for all scenarios. In the event that the UK leaves the EU without a deal at the end of this extension period, the Government has confirmed that the funding commitments made under the guarantee and the extension still stand. Through these commitments, the Government will underwrite funding for all successful competitive eligible UK bids to Horizon 2020 that are submitted before the end of the Programme. This guarantee will apply for the lifetime of projects and will provide funding for UK participation in pioneering Horizon 2020 medical research projects can continue.</p><p>Aside from our preparations for leaving the EU, the Government has demonstrated its commitment to research and innovation, including clinical drug trials, by putting it at the heart of its Industrial Strategy, setting an ambition to increase UK total research and development expenditure to 2.4% of gross domestic product by 2027. As a first step towards that we have invested an extra £7 billion in research and development up to 2021/2022. The Government invests over £1 billion in health research through the National Institute for Health Research. This provides direct funding for clinical trials and also the skills, facilities and infrastructure to undertake clinical trials in the health and care service funded by public, charity and industry funders.</p><p> </p><p><strong> </strong></p>
answering member constituency Gosport more like this
answering member printed Caroline Dinenage more like this
question first answered
less than 2019-06-20T15:31:03.907Zmore like thismore than 2019-06-20T15:31:03.907Z
answering member
4008
label Biography information for Dame Caroline Dinenage more like this
tabling member
116
label Biography information for Lord Soames of Fletching more like this